[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

BR112012027392A2 - heterobiaril-ciclo-hexil-tetra-azabenzo{e} azulenos - Google Patents

heterobiaril-ciclo-hexil-tetra-azabenzo{e} azulenos

Info

Publication number
BR112012027392A2
BR112012027392A2 BR112012027392A BR112012027392A BR112012027392A2 BR 112012027392 A2 BR112012027392 A2 BR 112012027392A2 BR 112012027392 A BR112012027392 A BR 112012027392A BR 112012027392 A BR112012027392 A BR 112012027392A BR 112012027392 A2 BR112012027392 A2 BR 112012027392A2
Authority
BR
Brazil
Prior art keywords
tetraazabenzo
azulenes
heterobiaryl
cyclohexyl
present
Prior art date
Application number
BR112012027392A
Other languages
English (en)
Inventor
Cosimo Dolente
Patrick Schnider
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of BR112012027392A2 publication Critical patent/BR112012027392A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
    • A61K31/5517—1,4-Benzodiazepines, e.g. diazepam or clozapine condensed with five-membered rings having nitrogen as a ring hetero atom, e.g. imidazobenzodiazepines, triazolam
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
    • A61P5/12—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH for decreasing, blocking or antagonising the activity of the posterior pituitary hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Endocrinology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Reproductive Health (AREA)
  • Psychiatry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Vascular Medicine (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Diabetes (AREA)
  • Hospice & Palliative Care (AREA)
  • Gynecology & Obstetrics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

"heterobiaril-ciclo-hexil-tetra-azabenzo{e} azulenos" a presente invenção refere-se a heterobiaril-ciclo-hexil-tetraazabenzo{e}azulenos de fórmula i em que r1,r2 e r3 são como descritos aqui.os compostos de acordo com a invenção agem como moduladores do receptor v1a ,e em particular como antagonistas do receptor v1 a sua fabricação ,composições farmacêuticas contendo -os e seu uso como medicamentos.os compostos ativos da presente invenção são úteis como produtos terapêuticos que agem perifericamente e centralmente nas condições de dismenorreia,disfusão sexual masculina ou feminina ,hipertensão ,insuficiência cardiaca crônica,secreção inapropiada de vasopressina,cirrose hepática,síndrome nef´rtica,ansiedade ,distúbios depressivos ,disturbio obsessivo compulsivo,distúrbios de espectro autístico ,esquizofrenia ,e comportamento agressivo.
BR112012027392A 2010-04-26 2011-04-21 heterobiaril-ciclo-hexil-tetra-azabenzo{e} azulenos BR112012027392A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP10161043 2010-04-26
PCT/EP2011/056391 WO2011134877A1 (en) 2010-04-26 2011-04-21 Heterobiaryl-cyclohexyl-tetraazabenzo[e]azulenes

Publications (1)

Publication Number Publication Date
BR112012027392A2 true BR112012027392A2 (pt) 2016-08-09

Family

ID=43991411

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112012027392A BR112012027392A2 (pt) 2010-04-26 2011-04-21 heterobiaril-ciclo-hexil-tetra-azabenzo{e} azulenos

Country Status (35)

Country Link
US (1) US8481528B2 (pt)
EP (1) EP2571879B1 (pt)
JP (1) JP5579925B2 (pt)
KR (1) KR101506778B1 (pt)
CN (1) CN102858778B (pt)
AR (1) AR081182A1 (pt)
AU (1) AU2011246553B2 (pt)
BR (1) BR112012027392A2 (pt)
CA (1) CA2794824A1 (pt)
CL (1) CL2012002954A1 (pt)
CO (1) CO6612268A2 (pt)
CR (1) CR20120515A (pt)
CY (1) CY1117145T1 (pt)
DK (1) DK2571879T3 (pt)
EA (1) EA021495B1 (pt)
EC (1) ECSP12012209A (pt)
ES (1) ES2553246T3 (pt)
HK (1) HK1176933A1 (pt)
HR (1) HRP20160051T1 (pt)
HU (1) HUE028018T2 (pt)
IL (1) IL222408A (pt)
MA (1) MA34173B1 (pt)
MX (1) MX2012012517A (pt)
MY (1) MY160977A (pt)
NZ (1) NZ602663A (pt)
PE (1) PE20130189A1 (pt)
PL (1) PL2571879T3 (pt)
PT (1) PT2571879E (pt)
RS (1) RS54418B1 (pt)
SG (1) SG184533A1 (pt)
SI (1) SI2571879T1 (pt)
TW (1) TWI419891B (pt)
UA (1) UA110031C2 (pt)
WO (1) WO2011134877A1 (pt)
ZA (1) ZA201207693B (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL2356123T3 (pl) * 2008-11-13 2013-03-29 Hoffmann La Roche Spiro-5,6-dihudro-4h-2,3,5,10b- tetraazabenzo[e]azuleny
CA2739900C (en) * 2008-11-18 2016-11-08 F. Hoffmann-La Roche Ag Alkylcyclohexylethers of dihydrotetraazabenzoazulenes
ES2431279T3 (es) 2008-11-28 2013-11-25 F. Hoffmann-La Roche Ag Arilciclohexiléteres de dihidro-tetraazabenzoazulenos para uso como antagonistas del receptor V1A de la vasopresina
US8420633B2 (en) 2010-03-31 2013-04-16 Hoffmann-La Roche Inc. Aryl-cyclohexyl-tetraazabenzo[e]azulenes
US8461151B2 (en) 2010-04-13 2013-06-11 Hoffmann-La Roche Inc. Aryl-/heteroaryl-cyclohexenyl-tetraazabenzo[e]azulenes
US8481528B2 (en) 2010-04-26 2013-07-09 Hoffmann-La Roche Inc. Heterobiaryl-cyclohexyl-tetraazabenzo[e]azulenes
US8513238B2 (en) 2010-05-10 2013-08-20 Hoffmann-La Roche Inc. Heteroaryl-cyclohexyl-tetraazabenzo[E]azulenes
CN115246781B (zh) * 2021-04-28 2024-03-29 南京正大天晴制药有限公司 一种沙芬酰胺的制备方法

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5516774A (en) * 1993-07-29 1996-05-14 American Cyanamid Company Tricyclic diazepine vasopressin antagonists and oxytocin antagonists
US5521173A (en) 1995-01-17 1996-05-28 American Home Products Corporation Tricyclic benzazepine vasopressin antagonists
AU756959B2 (en) * 1997-07-30 2003-01-30 Wyeth Tricyclic vasopressin agonists
CZ302647B6 (cs) 1999-01-19 2011-08-17 Ortho-Mcneil Pharmaceutical, Inc. Tricyklický benzodiazepin, farmaceutický prípravek s jeho obsahem a meziprodukty pro jeho prípravu
US7109193B2 (en) * 2001-04-12 2006-09-19 Wyeth Tricyclic diazepines tocolytic oxytocin receptor antagonists
US7022699B2 (en) 2001-04-12 2006-04-04 Wyeth Cyclohexenyl phenyl diazepines vasopressin and oxytocin receptor modulators
GB0303852D0 (en) 2003-02-19 2003-03-26 Pfizer Ltd Triazole compounds useful in therapy
EA009460B1 (ru) * 2003-02-19 2007-12-28 Пфайзер Инк. Триазольные соединения, полезные в терапии
GB0400700D0 (en) 2004-01-13 2004-02-18 Pfizer Ltd Compounds useful in therapy
CN1950374A (zh) 2004-05-25 2007-04-18 辉瑞产品公司 四氮杂苯并[e]甘菊环衍生物及其类似物
KR100840852B1 (ko) 2004-05-25 2008-06-23 화이자 프로덕츠 인크. 테트라아자벤조[ｅ]아줄렌 유도체 및 이의 유사체
GB0412874D0 (en) * 2004-06-09 2004-07-14 Pfizer Ltd Novel pharmaceuticals
EP1632494A1 (en) 2004-08-24 2006-03-08 Ferring B.V. Vasopressin v1a antagonists
MX2007002248A (es) 2004-08-25 2008-10-02 Pfizer Triazolobenzodiazepinas y su uso como antagonistas de vasopresina.
JP2008539220A (ja) 2005-04-26 2008-11-13 ファイザー・リミテッド バソプレシンアンタゴニストとしてのトリアゾール誘導体
US20080234252A1 (en) 2005-05-18 2008-09-25 Pfizer Inc Compounds Useful in Therapy
WO2008084005A1 (en) 2007-01-12 2008-07-17 F. Hoffmann-La Roche Ag Spiropiperidine glycinamide derivatives
CA2739900C (en) 2008-11-18 2016-11-08 F. Hoffmann-La Roche Ag Alkylcyclohexylethers of dihydrotetraazabenzoazulenes
US8420633B2 (en) 2010-03-31 2013-04-16 Hoffmann-La Roche Inc. Aryl-cyclohexyl-tetraazabenzo[e]azulenes
US8461151B2 (en) 2010-04-13 2013-06-11 Hoffmann-La Roche Inc. Aryl-/heteroaryl-cyclohexenyl-tetraazabenzo[e]azulenes
US8481528B2 (en) 2010-04-26 2013-07-09 Hoffmann-La Roche Inc. Heterobiaryl-cyclohexyl-tetraazabenzo[e]azulenes
US8513238B2 (en) 2010-05-10 2013-08-20 Hoffmann-La Roche Inc. Heteroaryl-cyclohexyl-tetraazabenzo[E]azulenes

Also Published As

Publication number Publication date
IL222408A (en) 2014-08-31
CO6612268A2 (es) 2013-02-01
PE20130189A1 (es) 2013-02-21
CN102858778A (zh) 2013-01-02
MA34173B1 (fr) 2013-04-03
ES2553246T3 (es) 2015-12-07
TWI419891B (zh) 2013-12-21
EA021495B1 (ru) 2015-06-30
EP2571879B1 (en) 2015-10-21
CY1117145T1 (el) 2017-04-05
EP2571879A1 (en) 2013-03-27
HUE028018T2 (en) 2016-11-28
HRP20160051T1 (hr) 2016-02-12
MY160977A (en) 2017-03-31
AR081182A1 (es) 2012-07-04
MX2012012517A (es) 2012-11-23
ZA201207693B (en) 2016-08-31
SI2571879T1 (sl) 2015-12-31
US20110263573A1 (en) 2011-10-27
NZ602663A (en) 2013-09-27
US8481528B2 (en) 2013-07-09
HK1176933A1 (en) 2013-08-09
KR101506778B1 (ko) 2015-03-27
KR20130031267A (ko) 2013-03-28
JP5579925B2 (ja) 2014-08-27
PL2571879T3 (pl) 2016-04-29
CN102858778B (zh) 2015-08-26
DK2571879T3 (en) 2015-11-09
UA110031C2 (xx) 2015-11-10
RS54418B1 (en) 2016-04-28
JP2013525396A (ja) 2013-06-20
WO2011134877A1 (en) 2011-11-03
CA2794824A1 (en) 2011-11-03
AU2011246553B2 (en) 2014-02-13
PT2571879E (pt) 2015-11-30
ECSP12012209A (es) 2012-10-30
CL2012002954A1 (es) 2013-04-12
SG184533A1 (en) 2012-11-29
TW201141870A (en) 2011-12-01
EA201291109A1 (ru) 2013-04-30
CR20120515A (es) 2012-11-01
AU2011246553A1 (en) 2012-10-18

Similar Documents

Publication Publication Date Title
BR112012024306A2 (pt) aril-cicloexil-tetraazabenzo[e] azulenos
BR112012026890A2 (pt) heteroarial-cicloexil-tetra-azabenzo[e] azulenos como antagonistas do receptor vasopressina v1a
BR112012027392A2 (pt) heterobiaril-ciclo-hexil-tetra-azabenzo{e} azulenos
BR112012028763A2 (pt) heteroaril-cicloexil-tetra-azatetra-azabenzeno[e]azulenos
BR112012025942A2 (pt) aril-/heteroaril-ciclo-hexenil-tetra-azabenzo[e]azulenos como antagonistas de vasopressina
ECSP11011089A (es) Arilciclohexiléteres de dihidro-tetraazabenzoazuleno
BR112014007851A2 (pt) ciclo-hexil-4h,6h-oxa-2,3,10b-triaza-benzo[e]azulenos como antagonistas de v1a
BR112015012555A2 (pt) derivados de benzimidazol como antagonistas de ep4
MX2015003653A (es) Derivados de amida del acido benzoimidazol-carboxilico como moduladores del receptor apj.
BR112015000578A2 (pt) moduladores da via do complemento e usos dos mesmos
BR112015010221A2 (pt) inibidores de cinase alk
BR112013021798A2 (pt) 1,4 tiazepinaas/sulfonas como inibidores de bace1 e/ou bace2
EA201591404A1 (ru) Спиролактамные модуляторы рецептора nmda и их применение
EA201490152A1 (ru) Антагонисты trpm8 и их применение при лечении
EA201492023A1 (ru) Регуляторы пути комплемента и их применение
MY165918A (en) Heterocyclic sulfonamides, uses and pharmaceutical compositions thereof
BR112012017756A2 (pt) moduladores crth2
BR112013017923A2 (pt) derivados de 2-metóxi-piridin-4-il
BR112014006945A2 (pt) óxi-ciclo-hexil-4h,6h-5-oxa-2,3,10b-triaza-benzo[e]azulenos como antagonistas de v1a
PT2313384E (pt) Fenil-alquil-piperazinas tendo uma actividade moduladora do tnf
EA201300981A1 (ru) Спироциклические циклопропановые аминокислоты и лекарственные средства на их основе

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 8A ANUIDADE.

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2515 DE 19-03-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.